Biological Methods
The following cell lines were obtained from ATCC: HEK293T (CRL3216), HEK293-STF (CRL-3249), SW620 (CRL-227), L (CRL-2648), L-Wnt3A (CRL-2647) and grown according to instructions from ATCC.
NOTUM cDNA was obtained from GE Dharmacon (Catalog #MHS6278-202806033) and subcloned into the pRK5 vector bearing a CMV promoter and C-terminus FLAG tag. The NOTUM S232A mutation was generated using the QuikChange II Site Directed Mutagenesis Kit (Agilent).
Compounds used in initial screening (Figure 1C): AA26-7, AA26-8, AA26-9, AA39-2, AA39-3,   AA44-2, AA74-1, KT109, KT116, KT117, KT185, KT195, KT205, KLH45, ABC5, ABC23, ABC34, ABC44, ABC45, and ABC47 were synthesized as previously described (AA compounds 2 , KT compounds 3 , KT185 4 , KLH45 5 , ABC compounds 1 ).
Transient Overexpression in HEK293T cells
HEK293T cells were seeded at 6 × 10 6 cells per 15 cm tissue culture plate and grown for 48
hours. Cells were then transfected with NOTUM, NOTUM S232A, or the control protein METAP2. For each transfection, 10 µg of each construct was incubated with 30 µL PEI MAX (1 mg/mL) in 1 mL of serum-free DMEM for 30 minutes, before being added to cells. Conditioned media was then collected as described below.
Preparation of Conditioned Media
Conditioned media was collected from HEK293T cells transiently overexpressing NOTUM, NOTUM S232A or the control protein METAP2. Media was removed 24 hours following transfection and cells were washed two times with warm PBS, and serum-free DMEM supplemented with 1 x PenStrep Glutamine was added. Media was collected on ice 48 hours later, cellular debris was pelleted (2,800g, 5 minutes) and the supernatant was applied to a 10,000 MWCO filter (EMD Millipore UFC701008) and concentrated at 4 °C (3,500g, ~30 minutes). One volume of cold PBS was then added to the concentrated media and the centrifugation step was repeated. Conditioned media was aliquoted, snap frozen, and stored at -80 °C for later use.
Conditioned media from SW620 cells was collected as above with the following modifications. SW620 cells were seeded at 5 × 10 6 per 15 cm plate, and allowed to grow to 60-80% confluency.
Cells were then washed twice with warm PBS, and serum-free RPMI supplemented with 1 x
PenStrep Glutamine was added. Media was collected 48 hours later and processed as described above.
Gel-based ABPP
In vitro and in situ competitive gel-based ABPP was performed as described previously. 3, 6 Briefly, after in vitro (30 min, 37 °C) or in situ (2 hours, 37 °C) inhibitor or DMSO treatment, cell lysates were treated with 1 µM FP-Rhodamine (FP-Rh) probe for 30 minutes at room temperature. Samples were then quenched with 4X SDS loading buffer, separated by SDS-PAGE on a 10% acrylamide gel and in-gel fluorescence was imaged using a ChemiDoc MP system.
Western Blotting
Following SDS-PAGE, gel samples were transferred onto nitrocellulose (50V, 2 hours), and blots were blocked with 5% milk TBS-T (30 min, RT), then incubated with anti-NOTUM antibody (Sigma-Aldrich HPA023041, 1:1000) overnight at 4°C. Blots were then washed with TBS-T (3x) and incubated with a secondary antibody (Li-cor IRDye 800CW Donkey anti-rabbit, 1:5000 in TBS-T with 5% milk) for 2 hours. Transfers were then washed again (3x, TBS-T) and imaged on a Li-cor Odyssey (Model 9120).
PPT1 Activity Profiling
Gel-based determination of PPT1 inhibition was carried out as described previously. 1 Briefly, SW620 cells were grown in 6 cm plates to ~80% confluency, and then treated with inhibitors or DMSO in situ for 2 hours. Cells were then scraped on ice, washed once with cold PBS, snap frozen and stored at -80 °C. Cell pellets were then thawed on ice, re-suspended in cold PBS and lysed with a probe sonicator. The lysates were pre-cleared (1,400g, 1 min) and the supernantant was fractionated by ultracentrifugation (100,000g, 45 min, 4 °C). The soluble fraction was collected, and sample concentrations were adjusted to 2 mg/mL. Samples were then incubated with 1 µM of the PPT1 probe ABC45 for 30 minutes at room temperature, and for an additional 30 minutes at 37 °C following addition of the de-glycosylating enzyme PNGaseF. A rhodamineazide (Rh-N 3 ) fluorophore reporter was conjugated onto the alkyne probe using CuAAC conditions as reported previously. 7 Proteome derived from either SW620 whole cell lysates (1 mg/mL), or from SW620 conditioned media (0.1 mg/mL) was treated with varying concentrations of ABC99yne for 30 minutes at room temperature, followed by clicking the fluorophore reporter rhodamine azide (Rh-N 3 ) with conditions as described above for PPT1 Activity Profiling.
Mass-spectrometry ABPP Sample Preparation and Data Analysis
Samples for quantitative mass spectrometric analysis were prepared and analyzed as previously reported with minor modifications specified below. 8 Inhibitor and DMSO treated proteomes from SW620 whole cell lysates (1 mg per condition), or SW620 conditioned media (0.5-0.75 mg per condition) were treated with 4 µM FP-biotin for 1 hour at room temperature. Samples were then precipitated using chloform/methanol, reduced with 10 mM neutral TCEP (30 minutes, 37 °C), alkylated with 40 mM iodoacetamide (30 minutes, room temperature), before being enriched with PBS-washed streptavidin-agarose beads (100 µL slurry, Thermo) for 1.5 hours at room temperature with end-over-end rotation. Samples were then washed with 0.2% SDS (2 x 10 mL), transferred to Low-bind eppendorf tubes, washed with 3 x 1 mL PBS, and 3 x 1 mL DI H 2 O, and then digested with sequence-grade trypsin (2 µg, Promega) in 2M urea overnight.
Samples were then labeled using reductive dimethylation (ReDiMe) as previously described. 5 Samples as prepared above were analyzed by LC/MS on a Thermo Finnigan instrument using a five-step multidimensional LC/MC MudPIT protocol, 9 with conditions as previously described.
Spectrum raw files were extracted into MS2 files using RawConverter (http://fields.scripps.edu/rawconv/) and searched using the ProLuCID algorithm 10 against a human reverse concatenated nonredundant Uniprot database, with static modifications for cysteine residues to account for alkylation by iodoacetamide (+57.0215 m/z), and standard static modifications for ReDiMe: lysine and N-terminus (+28.0313 m/z for light, +34.06312 m/z for heavy). Data was assembled using DTASelect version 2.0, 11 and ratio quantification was performed using in-house CIMAGE software. 9 Peptides were required to have an envelope correlation score of R 2 ≥ 0.8. Half tryptic peptides were discarded and ratios were capped to a maximum value of 20. Replicate data was combined with the requirement that proteins are quantified in at least two replicates. In cases where proteins had exactly one peptide with a calculated ratio of 20, and at least one other peptide with a ratio below 4, the 20 value was discarded.
Wnt Activity Assay
Wnt activity was assayed using the HEK293-STF cell line as described previously, 12 with some modifications. SW620 cells were seeded at a concentration of 5 × 10 6 in 10 cm plates. Two days later, media was collected, sterile filtered through a 22 µm syringe filter, and immediately incubated with inhibitors or DMSO for 1 hour at 37 °C, prior to being mixed 1:1 with freshly collected media from L, or L-Wnt3A cells (seeded at 2 × 10 6 per 10 cm plate, and processed the same way as media from SW620 cells). The mixture was then incubated at 37 °C for two hours, before being added to HEK293-STF (seeded at 3 × 10 4 per well of a 96-well plate 24 hours earlier).
Luminescence was then measured 24 hours later following replacement of media with 80 µL of Bright-Glo reagent (BioRad). Luminescence measurements for each condition were performed in quadruplicate.
Chemical Methods
Chemicals and solvents were purchased from reputable vendors and used without further purification. 1 H NMR spectra were obtained on a Bruker 500 mHz. Coupling constants (J) are reported in hertz. HRMS service was performed by the TSRI Center for Mass Spectrometry using an Agilent ESI-TOF instrument. All compounds were prepared as racemates. 
General Procedures
General Procedure A. Reductive Amination.
To a stirring solution of the amine containing compound in DCM (0.1 M, 1 eq), the aldehyde was added (4 eq), followed by sodium triacetoxyborohydride (2 eq), and finally acetic acid (catalytic, ~0.01 eq). The resulting solution was stirred overnight at room temperature, concentrated to a residue, and separated by prep-TLC. 
General Procedure B. Boc Deprotection.

Synthesis of NOTUM Inhbitors (2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(1H-imidazol-1-yl)methanone (ABC99_IU)
To a stirring solution of carbonyldiimidazole (Combi-Blocks) (1080 mg, 6.66 mmol) of DCM 
7-(4-bromobenzyl)-1,3-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl 4-(4-
methoxyphenyl
